Use of bacterial whole-genome sequencing to understand and improve the management of invasive Staphylococcus aureus infections.

Expert Rev Anti Infect Ther

a Microbiological Diagnostic Unit Public Health Laboratory , Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne , Australia.

Published: November 2016


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Management of invasive Staphylococcus aureus infections is complex. Dramatic improvements in bacterial whole genome sequencing (WGS) offer new opportunities for personalising the treatment of S. aureus infections. Areas covered: We address recent achievements in S. aureus genomics, describe genetic determinants of antibiotic resistance and summarise studies that have defined molecular characteristics associated with risk and outcome of S. aureus invasive infections. Potential clinical use of WGS for resistance prediction, infection outcome stratification and management of persistent /relapsing infections is critically discussed. Expert commentary: WGS is not only providing invaluable information to track the emergence and spread of important S. aureus clones, but also allows rapid determination of resistance genotypes in the clinical environment. An evolving opportunity is to infer clinically important outcomes and optimal therapeutic approaches from widely available S. aureus genome data, with the goal of individualizing management of invasive S. aureus infections.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14787210.2016.1233815DOI Listing

Publication Analysis

Top Keywords

aureus infections
16
management invasive
12
invasive staphylococcus
8
aureus
8
staphylococcus aureus
8
infections
6
bacterial whole-genome
4
whole-genome sequencing
4
sequencing understand
4
understand improve
4

Similar Publications

The complex interplay between circulating metabolites and immune responses, which is pivotal to disease pathophysiology, remains poorly understood and understudied in systematic research. Here, we performed a comprehensive analysis of the immune response and circulating metabolome in two Western European cohorts (534 and 324 healthy individuals) and one from sub-Saharan Africa (323 healthy donors). At the metabolic level, our analysis revealed sex-specific differences in the correlation between phosphatidylcholine and cytokine responses following ex vivo stimulation.

View Article and Find Full Text PDF

Orthopedic complications of sickle-cell disease in children.

Orthop Traumatol Surg Res

September 2025

Service de Chirurgie Orthopédique Pédiatrique, Hôpital Universitaire Robert-Debré, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, 48 Boulevard Sérurier, 75019 Paris, France.

Sickle cell disease is the most common serious genetic disease in the world. It is a systemic disease, characterized by vaso-occlusive phenomena, especially in the bone capillary network. Orthopedic complications are thus the most common, with a strong impact on quality of life.

View Article and Find Full Text PDF

Therapeutic Efficacy and Drug Metabolism of Griseorhodin A Induced by a Co-culture of Actinomycete Strain TMPU-20A002 and Mycobacterium smegmatis in Silkworm Infection Models.

Chem Pharm Bull (Tokyo)

September 2025

Division of Natural Product Chemistry, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.

In screening for antibacterial agents from co-cultures of Mycobacterium smegmatis and microbial resources, such as actinomycetes and fungi, the known hydroxyquinone antibiotic griseorhodin A (1) was isolated from a co-culture of actinomycete strain TMPU-20A002 and M. smegmatis. Compound 1 exhibited antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE), with minimum inhibitory concentrations of 0.

View Article and Find Full Text PDF

Injectable and tissue adhesive chrysomycin A-laden chitosan hydrogel depot for MRSA-infected wound healing and tumor recurrence prevention.

Int J Biol Macromol

September 2025

Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals & College of Pharmaceutical Science, Zhejiang University of Technology, 310014, Hangzhou, China. Electronic address:

Tumor surgery often leads to tumor residue, tissue defects, and drug-resistant bacterial infections, resulting in high recurrence rates and chronic wounds. In this study, an injectable hydrogel was synthesized using glycidyl trimethyl ammonium chloride-chitosan (GCh) and formylbenzoic acid-modified chrysomycin A (CA)-loaded F127 micelles (F127FA-CA). The formation of the hydrogel is achieved through Schiff base conjugation, which occurs between the amino groups present in GCh and the aldehyde groups located on the micelle surfaces.

View Article and Find Full Text PDF

Porous SiO/ZnO-carboxymethyl cellulose composite hydrogels for enhanced hemostatic efficacy and antibacterial activity.

Int J Biol Macromol

September 2025

School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong, 510006, China. Electronic address:

The development of effective hemostatic and antibacterial dressings remains a critical challenge in wound management. We report the design and fabrication of novel porous composite hydrogels composed of carboxymethyl cellulose (CMC), silica (SiO), and zinc oxide nanoparticles (ZnO NPs) . The incorporation of SiO and ZnO NPs into the CMC hydrogel matrix resulted in a unique multi-scale porous structure, characterized by interconnected holes of various sizes, which significantly enhanced the hydrogel's liquid absorption capacity and mechanical strength.

View Article and Find Full Text PDF